PCAS PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales for the 1st quarter of 2017.
The PCAS Group's consolidated net sales totaled €60.1 million in the 1st quarter of 2017, up 32.6% compared to the same period in the previous financial year (+32.3% at a constant exchange rate).
2017 | 2016 | % change | 2017 At a constant exchange rate | % change | |
in millions of euros | |||||
Net sales at 31 march | 60.1 | 45.3 | 32.6% | 59.9 | 32.3% |
Pharmaceutical synthesis | 42.7 | 30.2 | 41.1% | 42.7 | 41.1% |
Fine specialty chemicals | 17.4 | 15.1 | 15.6% | 17.3 | 14.5% |
The Pharmaceutical Synthesis business generated €42.7 million, up 41.1% on 2016 (+41.1% at a constant exchange rate), which was especially driven by the Exclusive activity, which was boosted by an exceptional order from an international client. Without that order, its growth would have stood at 16.3% (16.0% at a constant exchange rate).
Fine specialty chemicalsNet sales of Fine Specialty Chemicals totaled €17.4 million, up 15.6% on 2016 (+14.5% at a constant exchange rate), with growth in both Performance Additives and Advanced Specialty Chemicals.
Outlook for the current yearThe company thus confirms its targets for growth in net sales in 2017 and for all its lines of business (perhaps at a less rapid pace than the growth of the 1st quarter), thereby leading to an increase in net income.
NEXT FINANCIAL DISCLOSURE: |
2017 Annual General Meeting in Longjumeau at 10 a.m. on Wednesday, June 28, 2017 |
PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €192.0 million in 2016 and employs close to 1000 people in six countries.
To find out more about PCAS, visit: www.pcas.com
PCAS | NewCap |
Vincent Touraille / Eric Moissenot PCAS | Emmanuel Huynh / Louis-Victor Delouvrier NewCap Financial communication and Investor Relations |
Tel. : +33 1 69 79 61 32 www.pcas.com | Tel. : +33 1 44 71 98 53 pcas@newcap.eu |
PCAS SA published this content on 15 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 May 2017 16:57:19 UTC.
Original documenthttp://www.pcas.com/content/download/4470/72811/version/2/file/CP PCAS - CA T1 2017_FR_ENU.pdf
Public permalinkhttp://www.publicnow.com/view/C85B85E911B1946B91BFCBF1F7C0175CB8F255DD
